Researchers are cutting short travel, ending collaborations and rethinking their US ties.

Editor asked to resign from journal for saying he’ll review only papers whose data he can see.

Amendments aim to protect autonomy and the independence of research funders from political interference.

Nobel-winning inventor of ways to modify genes

Global research funds for these illnesses are at their lowest levels for a decade, when cash for West Africa epidemic is excluded.

The provisional agreement may set a precedent for other funders and journal publishers.

Publisher restores access as negotiations for a nationwide licence continue.

Coalition of scientists and research agencies argue for a one-stop shop server.

Nearly 100 founders and leaders of biotech companies express their deep concern and opposition to the executive order signed by President Donald Trump on January 27, 2017.

Two countries vie to invest more of their economy into research than anyone else.

John Holdren worries that immigration restrictions could harm researchers' ability to collaborate across borders.

Order barring citizens of seven countries from entering the United States has left many confused and afraid.

Michael Eisen hopes a victory in 2018 will bring a new scientific voice to the US legislature.

Open-science advocate says journals should be clearer to peer-reviewers about terms and conditions.

A geneticist's decision not to publish his finalized preprint in a journal gets support from scientists online.

Shift in focus comes in response to a changing world order and the threat of terrorism.

Reproducibility guru, former defence-research official and controversial entrepreneur rumoured to be on list, along with current NIH leader and a congressman.

Publications such as Nature and Science have policies that clash with the global health charity's open-access mandate.